Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC
Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC
EAU 2024: Bladder cancer latest
Concurrent low-dose radiation and durvalumab and etoposide/platinum shows promising efficacy in 1L ES-SCLC
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status
Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients
Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer
Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Treatment of multiple myeloma in Singapore and Asia
Optimising multiple myeloma care in Latin America
Special Issue on paediatric oncology
Global trends and inequalities in breast cancer survival and care